Optimizing Care With a Standardized Management Protocol for Patients With Infantile Spasms
- 22 December 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 30 (10) , 1340-1342
Abstract
The primary aim of this quality improvement initiative was to increase the number of patients receiving first-line therapy (adrenocorticotropic hormone, corticosteroids, vigabatrin) as the initial treatment for infantile spasms. We implemented a standardized management protocol for infantile spasms based on the best available data and expert consensus. To assess the impact of this intervention, we compared the 3-month remission rates between prestandardization (January 2009 to August 2012) and poststandardization (September 2012 to May 2014) cohorts. We found that the percentage of patients receiving first-line therapy as the initial treatment was 57% (31/54) in the prestandardization cohort and 100% (35/35) in the poststandardization cohort (P < .001). The rate of infantile spasms remission was higher poststandardization compared to prestandardization (78.8% vs 30.6%, P < .001). Management standardization led to all patients receiving first-line therapy as the initial treatment and was associated with a significantly improved rate of infantile spasms remission 3 months after diagnosis.Keywords
This publication has 8 references indexed in Scilit:
- The Current Evaluation and Treatment of Infantile Spasms Among Members of the Child Neurology SocietyJournal of Child Neurology, 2012
- Evidence-based guideline update: Medical treatment of infantile spasms [RETIRED]Neurology, 2012
- Effect of Price Increase of Adrenocorticotropic Hormone on Treatment Practices of Infantile SpasmsPediatric Neurology, 2010
- Infantile spasms: A U.S. consensus reportEpilepsia, 2010
- Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE projectBMJ, 2009
- Practice Parameter: Medical Treatment of Infantile SpasmsNeurology, 2004
- Long‐term Cognitive Outcomes of a Cohort of Children with Cryptogenic Infantile Spasms Treated with High‐dose Adrenocorticotropic HormoneEpilepsia, 2004
- Long-term outcome of patients with West syndromeBrain and Development, 2001